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A B S T R A C T
The presence of cortical lesions in multiple sclerosis patients has emerged as an important biomarker of the
disease. They appear in the earliest stages of the illness and have been shown to correlate with the severity of
clinical symptoms. However, cortical lesions are hardly visible in conventional magnetic resonance imaging
(MRI) at 3T, and thus their automated detection has been so far little explored. In this study, we propose a fully-
convolutional deep learning approach, based on the 3D U-Net, for the automated segmentation of cortical and
white matter lesions at 3T. For this purpose, we consider a clinically plausible MRI setting consisting of two MRI
contrasts only: one conventional T2-weighted sequence (FLAIR), and one specialized T1-weighted sequence
(MP2RAGE). We include 90 patients from two different centers with a total of 728 and 3856 gray and white
matter lesions, respectively. We show that two reference methods developed for white matter lesion segmen-
tation are inadequate to detect small cortical lesions, whereas our proposed framework is able to achieve a
detection rate of 76% for both cortical and white matter lesions with a false positive rate of 29% in comparison
to manual segmentation. Further results suggest that our framework generalizes well for both types of lesion in
subjects acquired in two hospitals with different scanners.
1. Introduction
Multiple Sclerosis (MS) is a chronic demyelinating disease involving
the central nervous system (CNS). An estimated 2 million people are
currently having the disease worldwide (Reich et al., 2018). MS is
characterized by sharply delimited lesional areas with primary de-
myelination, axonal loss, and reactive gliosis, both in the white and in
the grey matter. However, the pathological process is not confined to
these macroscopically visible focal areas but is generalized in the entire
central nervous system (Compston and Coles, 2008; Kuhlmann et al.,
2017).
Magnetic resonance imaging (MRI) is the imaging tool of choice to
detect such lesions in both the WM and GM of the CNS. The current MS
diagnostic criteria (McDonald criteria (Thompson et al., 2018)) are also
based on the count and location of lesions in MRI. Common MRI pro-
tocols currently include T1-weighted (T1w), T2-weighted (T2w), and
fluid-attenuated inversion recovery T2 (FLAIR) sequences. For many
years, the main focus in research and clinical practice has been set on
white matter lesions (WMLs), clearly visible in the above-mentioned
conventional MRI sequences. In the last decade, however, cortical
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damage has emerged as an important aspect of this disease. Recent
studies have shown that the amount and location of cortical lesions
(CLs), visible mostly on advanced MRI sequences at high (3T) and ultra-
high (7T) magnetic field, correlate better with the severity of the cog-
nitive and physical disabilities than those of WMLs (Calabrese et al.,
2009). Since 2017, CLs are also included in the above-mentioned MS
diagnostic criteria (Thompson et al., 2018). Consequently, specialized
MR sequences with greater sensitivity to detect CLs, such as magneti-
zation-prepared 2 rapid acquisition with gradient echo (MP2RAGE)
(Kober et al., 2012; Marques et al., 2010) and double inversion recovery
(DIR) (Wattjes et al., 2007), are now more and more used in the clinical
setting (Filippi et al., 2019).
Currently, manual segmentation on clinical MRI is considered the
gold standard for MS lesion identification and quantification. However,
given how time-consuming this process is, several methods for auto-
mated MS lesion segmentation have been proposed in the literature
(Kaur et al., 2020). These can be broadly classified into supervised and
unsupervised approaches. The former ones rely on a manually labeled
training set and aim at learning a function that maps the input to the
desired output. The latter do not require manual annotations as they are
based on generative models that rely on modeling the MRI intensities
values of different brain tissues and lesions (Lladó et al., 2012).
Deep learning algorithms are particularly suited for image seg-
mentation tasks and dominate leader-boards of biomedical imaging
processing challenges, including the segmentation of MS WMLs (Carass
et al., 2017). Specifically, several convolutional neural network (CNN)
architectures have been tailored for the segmentation of MS WMLs
(Kaur et al., 2020). Some of them employ 2D convolutional layers
(Aslani et al., 2019; Roy et al., 2018), whereas others employ 3D con-
volutional layers to incorporate information from all three spatial di-
rections simultaneously (Hashemi et al., 2019; La Rosa et al., 2019;
Valverde et al., 2017, 2019). The clear edge these methods have over
classical approaches is the capability of automatically extracting the
relevant features for the task. Their application and generalization in
clinical datasets, however, remains to be proved. They have often
considered only 2D MRI sequences and segmentations were performed
with a large minimum lesion volume threshold; for instance, Valverde
et al. (2017) set this value to 20 voxels for the clinical MS datasets.
Moreover, apart from (Valverde et al., 2019), all these deep learning
methods are currently not publicly available. Finally, with the excep-
tion of our previous work (La Rosa et al., 2019), they have not been
evaluated on CLs.
Compared to WMLs, imaging of CLs faces additional challenges due
to their pathological features (Filippi et al., 2019). While WMLs can be
automatically detected with high accuracy (Carass et al., 2017) from
conventional MRI sequences, such as MPRAGE and FLAIR, CLs, which
affect mostly the more superficial and less myelinated layers of the
cortex (Filippi et al., 2019), have a low contrast to surrounding tissue
with clinical MS MRI protocols. As mentioned above, the detection of
CLs, at least at 3T, requires specialized imaging such as MP2RAGE and
3D DIR (Kober et al., 2012; Wattjes et al., 2007), and the number of
lesions visible is still low in comparison to histopathology (about 20%)
(Calabrese et al., 2010). These advanced imaging requirements limit
the access to large training datasets. Furthermore, the automated de-
tection of CLs is challenging as the number, volume, and location of CLs
varies substantially across subjects (see Fig. 2).
To the best of our knowledge, only three studies explored the si-
multaneous segmentation of CLs and WMLs at 3T (Fartaria et al., 2016,
2017; La Rosa et al., 2019). Our first approach was based on a k-nearest
neighbors (k‐NN) classifier (Fartaria et al., 2016), which was later on
improved by including a partial volume tissue segmentation framework
(Fartaria et al., 2017) to better delineate the lesions. In Fartaria et al.
(2016)), we considered a multi-modal MRI framework including 3D
MP2RAGE, 3D FLAIR, and 3D DIR sequences. Compared to manual
segmentation, an overall WML and CL detection rate of respectively
77% and 62% was achieved. Recently, we have also explored the ability
of deep learning architectures (La Rosa et al., 2019). We proposed an
original 3D patch-wise CNN that improved lesion-wise results with re-
spect to Fartaria et al., 2016). The main limitation of both approaches,
however, was that training and testing them without the DIR sequence
caused a significant drop in performance (CL detection rate from 75%
to 58% in (La Rosa et al., 2019). Unfortunately, the DIR sequence is not
widely acquired in clinics due to its long acquisition time (about
13 min) and frequent artefacts (Filippi et al., 2019), thus being for now
mostly used for research purposes.
This study complements the literature with an evaluation of a deep
learning method to segment CLs and WMLs based on two MRI se-
quences only (3D FLAIR and MP2RAGE, see Fig. 1) acquired at 3T. This
choice reflects a clinically plausible set of input data that is not dis-
ruptive of established processes. Our aim is to provide a segmentation
framework for different types of MS lesions, large and small, with a
minimum lesion size of 3 voxels as recommended in the guidelines for
MS CLs (Geurts et al., 2005). We propose a fully-convolutional archi-
tecture inspired by the 3D U-Net (Çiçek et al., 2016). Compared to our
previous studies, we significantly extend our cohort of patients to 90
subjects from two different clinical centers. We evaluate the method
firstly with a 6-folds stratified cross validation over the entire cohort
and secondly with a train-test split.
Fig. 1. From left to right a sagittal slice of the FLAIR, manual lesion segmentation mask overlaid on the FLAIR, and MP2RAGE contrast. Colorcode of overlay: WMLs
in red and CLs in green. The zoomed-in WML is clearly visible in FLAIR, whereas the MP2RAGE shows a higher contrast for the CL. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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2. Materials and methods
2.1. Datasets
In this study, we consider two datasets for a total of 90 subjects
overall. Dataset I includes patients at different stages of the disease,
whereas Dataset II only at the early stages. Refer to Fig. 2 for an analysis
of the differences between the datasets in terms of lesion volume and
lesion count per patient.
2.1.1. Dataset I
Images for Dataset I were acquired at Basel University Hospital from
54 patients (35 female / 19 male, mean age 44 ± 14 years, age range
[22–73] years). According to the revised McDonald criteria (Thompson
et al., 2018), 39 of these were diagnosed with relapsing remitting MS, 8
with primary progressive MS, and 7 with secondary progressive MS.
Expanded Disability Status Scale (EDSS) scores ranged from 1 to 7
(mean 3.2 ± 1.9). Imaging was performed on a 3T MRI scanner
(MAGNETOM Prisma, Siemens Healthcare, Erlangen, Germany) with a
64-channel head and neck coil. The following 3D sequences were ac-
quired with a 1 mm3 isotropic spatial resolution: 3D-FLAIR
(TR,TE,TI = 5000, 386, 1800 ms, acquisition time = 6 min), and a
prototype MP2RAGE (TR,TE,TI1,TI2 = 5000, 2.98, 700, 2500 ms, ac-
quisition time = 8 min). The study was approved by the Ethics Com-
mittee of our institution, and all patients gave written informed consent
prior to participation.
2.1.2. Dataset II
Images for Dataset II were acquired at Lausanne University Hospital
from 36 patients (20 female / 16 male, mean age 34 ± 10 years, age
range [20–60] years) diagnosed with relapsing remitting MS. Expanded
Disability Status Scale (EDSS) scores ranged from 1 to 2 (mean
1.5 ± 0.3). Imaging was performed on a 3T MRI scanner (MAGNETOM
Trio, Siemens Healthcare, Erlangen, Germany) with a 32-channel head
coil. The following 3D sequences were acquired with a resolution of
1 × 1 × 1.2 mm3: 3D-FLAIR (TR,TE,TI = 5000, 394, 1800 ms, ac-
quisition time = 6 min), and a prototype MP2RAGE
(TR,TE,TI1,TI2 = 5000, 2.89, 700, 2500 ms, acquisition time = 8 min).
The study was approved by the Ethics Committee of our institution, and
all patients gave written informed consent prior to participation.
2.1.3. Manual segmentation
WMLs appear as hyperintense areas in T2w images and as hy-
pointense in T1w images and are usually well visible in conventional
sequences at 3T. On the contrary, the majority of CLs cannot be clearly
seen in FLAIR at 3T and specialized sequences as the MP2RAGE im-
prove their detection (see Figs. 1 and 6). In Dataset I, all lesions were
detected and classified by consensus by a neurologist and a medical
doctor with 11 and 5 years of experience in MS research, respectively.
The medical doctor then manually segmented all lesions. In Dataset II
both WMLs and CLs were manually detected and classified by consensus
by the same neurologist who annotated Dataset I and one radiologist
with 7 years of experience, using both imaging modalities. Their
agreement rate prior to consensus was of 97.3%. The lesion borders
were then delineated in each image looking at multiple planes by a
trained technician. In total in our two datasets, 3856 WMLs and 728 CLs
were manually labeled.
Furthermore, CLs were classified by a single expert in different
subtypes according to (Calabrese et al., 2010). Cortical MS lesions can
extend across the WM and GM (leukocortical, type I), can be contained
entirely in the gray matter without extending to the surface of the brain
or to the subcortical WM (pure intracortical, type II), or can be wide-
spread from the outer to the inner layers of the cortex without peri-
venous distribution and often over multiple gyri (subpial, type III).
Within our cohort, the majority (89%) of the cortical lesions identified
belonged to type I, 11% to type II, and only 0.01% to type III. Given the
high imbalance between different subtypes, in the automated segmen-
tation analysis we pool all CLs together.
Lesions smaller than 3 voxels were automatically re-classified as
background in the ground truth and in the predictions. This is equal to a
volume of 3 µL for the lesions in Dataset I and 3.6 µL for the lesions in
Dataset II. It should be noted that 3 µL corresponds to the consensus
recommended minimum CL size in the 3D DIR sequence (Geurts et al.,
2005), and we chose this as the minimum lesion size in our study as
Fig. 2. Distribution of the lesion volume and count per patient in our two datasets, considering WMLs and CLs separately. In the first row each patient has a blue dot
corresponding to its WML volume and an orange dot for the CL one. In the second row this is repeated with the lesion count. Boxplots are added to summarize the
distribution of each dataset. For visualization purposes jitter is added to the true EDSS value. (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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currently there is no guideline for the MP2RAGE. The distribution of the
subject-wise total lesion volume and lesion count in our cohort can be
seen in Fig. 2.
2.2. Methodology
U-Net Our network architecture is based on the 3D U-Net (Çiçek
et al., 2016; Ronneberger et al., 2015). The U-Net architecture in-
tegrates an analysis path, where the number of feature maps are in-
creased while the image resolution is being reduced, and a synthesis
path where the resolution is increased and number of features decrease,
yielding a semantic segmentation output. Several variants of it have
been proposed, for example changing the resolution levels, varying the
number of convolution layers or introducing residual blocks. The U-Net
has been tested on different biomedical imaging segmentation appli-
cations, and methods based on it or on its 3D implementation (Çiçek
et al., 2016) have won several segmentation challenges (Myronenko,
2018; Isensee and Maier-Hein, 2019). Two variants of the U-Net were
also specifically proposed for MS WML segmentation (Kumar et al.,
2019; Feng et al., 2018). Kumar et al. (2019) have proposed a dense 2D
U-Net and showed promising results on a challenge dataset (Carass
et al., 2017), even though the method was not compared to other deep
learning approaches. Feng et al. (2018) have presented a standard 3D
U-Net with advanced data augmentation, but again this work lacked an
evaluation on a clinical dataset or a proper comparison with other state-
of-the-art methods.
2.2.1. Proposed architecture
Compared to the original implementation of the U-Net, we reduce
the number of resolution levels from four to three (therefore 3D U-Net-)
because of the limited number of available CLs. By doing so, we dras-
tically reduce the number of trainable parameters from 18.3 M to 3.8 M
and thus decrease the risk of overfitting. Furthermore, our choice of a
3D architecture is motivated by the fact that the input modalities FLAIR
and MP2RAGE are both 3D acquisitions, and therefore we want to fully
exploit the volumetric anatomical information. The 3D U-Net- archi-
tecture integrates a spatial context of 41 voxels. In our experiments, we
use an input shape of (88, 88, 88) and because no padding is applied
through the network the output size was (48, 48, 48) (see Fig. 3). In the
analysis path, the 3D convolutional filters (each followed by a ReLu
activation function) has respectively 32, 64, 64, 128, and 128 filters.
The decoder has the following number of feature maps: 256, 128, 128,
64, 64, 1. Skipped connections are present as in the original im-
plementation (Çiçek et al., 2016).
2.2.2. Pre-processing
The only pre-processing step performed is a rigid registration based
on mutual information of the FLAIR image of each subject to the cor-
responding MP2RAGE (UNI contrast) image with ELASTIX (Klein et al.,
2010). Each multi-step pre-processing pipeline, for instance, skull
stripping and/or bias field correction has its own data dependent effect
on the performance. While we cannot exclude the possibility that a
certain combination of pre-processing steps would lead to better per-
formance for a given data set, we reduce the model-related sources of
variance in performance to the network architecture and its training,
which leads to an integrated solution that facilitates evaluation and
incremental improvements.
2.2.3. Training
Prior to training all input volumes are normalized with zero mean
and unit variance. We implement a sampling strategy by which each
connected component in the ground truth has the same possibility of
being sampled, regardless of its size. Thus, we encourage the network to
focus also on the smaller structures such as CLs. L2 regularization was
used with a regularization factor of 1e-5. The network is trained with a
pixel-wise weighted cross-entropy loss function with the following
weights: background 1, WMLs 1, CLs 5. This is motivated by the fact
that there are about 5 times less CLs than WMLs in each fold of our
dataset. The learning rate is initially set to 1e-8 and gradually increased
in the first 2000 iterations to 1e-4 in a warm-up phase. Afterwards it is
reduced by half every 10,000 iterations. The batch size is set to 2, and
Adam is used as optimizer. The validation loss is monitored with early
stopping to determine when to stop the training.
2.2.4. Data augmentation
Data augmentation is a well-known technique for deep neural net-
works to increase the performance in the testing set. In our work, ex-
tensive data augmentation is performed on-the-fly to prevent
Fig. 3. 3D U-Net- architecture proposed. On the left, examples of input patches in the two contrasts used, and on the right the relative lesion mask obtained in output.
F. La Rosa, et al. NeuroImage: Clinical 27 (2020) 102335
4
overfitting. The transformations are carefully chosen as, since we are
dealing with large 3D patches, excessive augmentation would slow
down the training. More specifically, we apply random rotation of the
input volumes around the z axis only up to 90°, random spatial scaling
up to 5% of the volume size, and random flipping along all three axes.
2.2.5. Implementation
The code is implemented in the Python language in the NiftyNet
framework (Gibson et al., 2018) based on TensorFlow (Abadi, 2016).
The software requires Python version 3.6. Training also requires CUDA/
cuDNN libraries by NVIDIA and compatible hardware. The code is
publicy available along with a trained model1.
2.3. Evaluation
2.3.1. Comparison with other related methods
For comparison, we evaluated two state-of-the-art MS WML seg-
mentation methods publicly available:
• LST-LGA is an unsupervised lesion growth algorithm (Schmidt et al.,
2012) implemented in the LST toolbox version 3.0.0 (LST, 2020) for
Statistical Parametric Mapping (SPM). LST-LGA has been widely
evaluated in the context of MS WML segmentation and used as
comparison with more recent approaches (Aslani et al., 2019;
Valverde et al., 2017; Roy et al., 2018). In a nutshell, the algorithm
performs an initial bias field correction and affine registration of the
T1 image (in our case the MP2RAGE) to the FLAIR, and then pro-
ceed with the lesion segmentation. Lesions are identified based on a
voxel-wise binary regression with spatially varying parameters. We
applied LST-LGA with the default initialization parameters
(kappa = 0.3, MRF = 1, maximum iterations = 50). The final
threshold to obtain a binary segmentation mask was optimized in
the validation set by maximizing the dice coefficient.
• nicMSlesions is a state-of-the-art deep learning WML segmentation
method (Valverde et al., 2017, 2019). Having reached an excellent
performance in a MS lesion segmentation challenge (Carass et al.,
2017), it is now a common method to compare with (Aslani et al.,
2019; Weeda et al., 2019; Roy et al., 2018). This method selects
lesion candidates’ voxels based on the FLAIR contrast and extracts
11x11x11 patches around them. A double CNN is then trained to
first find lesion candidates and then reduce the false positive rate.
The pipeline includes as pre-processing steps a registration of the
different modalities to the same space, skull-stripping, and de-
noising. This approach was run with all the default parameters, in-
cluding a maximum of 400 epochs, early stopping, and the patient
value set to 50 epochs.
2.3.2. Evaluation strategies and metrics
We evaluated the three methods in two different scenarios (see
Fig. 4). First, we performed a stratified 6-folds cross validation pooling
data from Dataset I and II. Second, we trained the supervised methods
on the subjects of Dataset I and evaluated using data from Dataset II.
Results were evaluated quantitatively with the manually delineated
masks. We computed the following, widely used (Carass et al., 2017;
Kaur et al., 2020; Lladó et al., 2012), evaluation metrics: dice coeffi-
cient (DSC), absolute volume difference (AVD), voxel-wise positive
predicted value (PPV), lesion-wise true positive rate (LTPR), lesion-wise
false positive rate (LFPR), WML detection rate (LTPR_WM), CL detec-
tion rate (LTPR_CL) as defined here (Carass et al., 2017).
Statistical analysis was also performed at the patient-wise level
using the SciPy Python library (SciPy 1.0 Contributors et al., 2020). As
the distributions violate the normality assumptions, Wilcoxon signed
rank test was used to statistically test differences in LTPR_WM,
LTPR_CL, and LFPR. All tests were adjusted for multiple comparison
using a Bonferroni correction. Statistical differences were considered
for p-value < 0.05. We computed the Pearson's linear correlations




There were 75 training cases from which 20% (15 patients) were
used as validation set to determine early stopping and optimize the
threshold and 15 testing cases in each fold (see Fig. 4). The threshold
was chosen as the value (with intervals of 0.05) that gave the highest
dice coefficient in the validation set. Qualitative results are reported in
Fig. 5, where the first row shows a slice of a subject from Dataset I, and
the second row one from a subject of Dataset II. Moreover, in Fig. 6 we
show examples of CLs correctly detected by our proposed 3D U-Net-.
The median of all metrics obtained in the test folds of the cross-
validation are shown in Table 1. 3D U-Net- achieves a 75% CL detection
rate and the best performance in all metrics except for the PPV, for
which LST-LGA has the best value (71%). Overall, the results of 3D U-
Net- and nicMSlesions are in line with other recent works, both for
WMLs (Carass et al., 2017) and for CLs (Fartaria et al., 2016; La Rosa
et al., 2019).
We further analyzed the patient-wise LTPR and LFPR by the box-
plots in Fig. 7. 3D U-Net- significantly outperforms the other two
methods in the three detection accuracy metrics (refer to Fig. 7 for the
p-values). Moreover, there is only a slight difference between the 3D U-
Net- CL and WML detection rate.
Fig. 8 shows the correlation between the manually segmented lesion
volumes and the ones automatically estimated. On the identity lines the
predicted and estimated volumes are equal an the closer the results are
to the line, the more accurate. The solid lines show the linear regression
model fitted with these points, and the Pearson's linear correlation
coefficient is reported for each method in the legend.
We also analyzed the results per lesion size range. As mentioned
above, we decided to stay below the MS WML minimum size re-
commended in the diagnostic criteria, as our datasets include also CLs.
In Fig. 9 is presented the detection rate for WMLs and CLs separately for
the three methods.
Fig. 4. Scheme of the two evaluation scenarios.
1 La Rosa, Francesco, Abdulkadir. Ahmed, Thiran, Jean-Philippe, Granziera,
Cristina, & Bach Cuadra, Merixtell. (2020, July 7). Software: Multiple sclerosis
cortical and WM lesion segmentation at 3T MRI: A deep learning method based
on FLAIR and MP2RAGE (Version v1.0). Neuroimage: Clinical. Zenodo. http://
doi.org/10.5281/zenodo.3932835
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3.2. Independent test set
In the second scenario we aim at exploring the generalization of our
segmentation framework by training on one single center while testing
on the other one (see Fig. 4). We trained a model on Dataset I, keeping
20% of the cases for validation (n = 11), and evaluated the
Fig. 5. Visual illustration of results for all three methods. In the first row is presented a subject from Dataset I, and in the second row a subject from Dataset II.
Colorcode of overlay of the ground truth (GT): WMLs in red and CLs in green. The yellow arrows point at false positives of the automatic methods, whereas the light
blue arrows at false negatives. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 6. Four examples of correctly detected cortical lesions by our proposed method. All lesions are better visible in the MP2RAGE sequence compared to the FLAIR.
Table 1
Median values (IQR) of the metrics obtained for the different methods on the cross-validation evaluation (90 subjects). The minimum lesion size is 3 voxels. The last
column shows the inference time. The best result per each metric is shown in bold.
Method Dice AVD PPV LTPR LTPR_WM LTPR_CL LFPR Time (s)
LST-LGA 0.36 (0.19) 0.60 (0.31) 0.71 (0.34) 0.36 (0.24) 0.38 (0.25) 0.10 (0.33) 0.36 (0.35) 370
nicMSlesions 0.53 (0.28) 0.32 (0.43) 0.52 (0.43) 0.65 (0.26) 0.67 (0.26) 0.53 (0.39) 0.45 (0.40) 430
3D U-Net- 0.62 (0.16) 0.27 (0.30) 0.61 (0.23) 0.76 (0.20) 0.77 (0.22) 0.75 (0.50) 0.29 (0.25) 20
Fig. 7. Boxplots of the patient-wise metrics obtained for the three methods. The p-values are computed with the Wilcoxon signed rank test.
F. La Rosa, et al. NeuroImage: Clinical 27 (2020) 102335
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performance on the independent data of Dataset II. This setting simu-
lates a more realistic scenario where our method is evaluated with
imaging data acquired outside the training site. Moreover, let us note
that patients in Dataset II are at very early stages of MS with EDSS scale
ranging between 1 and 2 only (see Fig. 2).
In Table 2 we report the quantitative criteria evaluated on an in-
dependent test set. Our proposed method achieves a 71% CL detection
rate and outperformed the others in all metrics except for the PPV and
the LTPR_WM, for which it achieves the best results (69%) together
with nicMSlesions. Finally, in Fig. 10 we show the boxplots for the WM
and CL LTPR, and the LFPR, with their relative significant differences
performed with the Wilcoxon signed rank test.
4. Discussion
With a simple deep learning architecture that was trained end-to-
end and did not include explicit feature engineering or advanced pre-
processing, we segmented CLs and WMLs using one conventional and
one specialized MRI contrast with a detection rate of 76% (median) and
lesion false positive rate of 29% (median). The proposed prototype 3D
U-Net- outperformed the baseline methods and proved to generalize
well for cases acquired with a different scanner. Consequently, we
foresee our proposed method as a useful support tool in a research
setting where MS CLs and WMLs need to be segmented in a high
number of MRI scans. The automatic segmentation obtained could, for
instance, represent a first lesion labelling to then be refined by the
experts, allowing them to further standardize and speed up the overall
process.
As reflected by being recently introduced in the MS diagnostic cri-
teria (Thompson et al., 2018), CLs are of great clinical interest, yet their
automated segmentation has been receiving little attention. The fully-
convolutional 3D U-Net- has a relatively low number of training para-
meters (3.8 M) and it is fast to run at inference time (about 20 s to infer
a new subject, not counting initial intra-subject registration). The
method was evaluated on two datasets of 54 and 36 subjects, respec-
tively. In order to emulate a realistic clinical setting, we considered a
minimum lesion size of 3 voxels, which is the recommended minimum
size of CLs for 3D sequences with at least 1 mm voxel spacing (Geurts
et al., 2005). This is smaller than what previous automatic studies have
reported for WM lesions (20 voxels in (Valverde et al., 2017), for in-
stance), and also much smaller than the clinical definition of minimum
WML diameter of 3 mm (Grahl et al., 2019; Thompson et al., 2018)
corresponding in a spherical approximation to a volume of about
14 mm3.
We compared our proposed approach with two reference methods:
an unsupervised lesion growth approach (LST-LGA) and a supervised
deep learning technique (nicMSlesions), both of which were originally
proposed for MS WML segmentation only. Our first evaluation consisted
in a 6-folds per site stratified cross validation including all 90 subjects.
In this way, we evaluated the performance over a large dataset, with
significant variability of lesion count and volume across subjects. We
considered the main metrics evaluated in MS lesion segmentation
Fig. 8. Correlation between the manual lesion volume and the automatically segmented one. The solid lines show the linear regression model between the two
measures along with confidence interval at 95%. The dashed lines indicate the expected lesion volume estimates. The Pearson's linear correlation coefficient between
manual and automatic lesion volume is reported in the legend (r = 0.84 for LST, r = 0.87 for nicMSlesions, r = 0.94 for 3D U-Net-.
Fig. 9. Detection rate for WMLs and CLs for the three methods evaluated considering different lesion size ranges. In parenthesis are reported the total number of
lesions of each range. The dashed line shows the minimum lesion size established for WMLs.
Table 2
Median values (IQR) of the metrics obtained for the different methods on the independent test set (36 subjects). The minimum lesion size is 3 voxels. The last column
shows the inference time. The best result per each metric is shown in bold.
Method Dice AVD PPV LTPR LTPR_WM LTPR_CL LFPR Time (s)
LST-LGA 0.32 (0.27) 0.63 (0.25) 0.75 (0.29) 0.28 (0.21) 0.30 (0.19) 0.19 (0.20) 0.35 (0.34) 370
nicMSlesions 0.58 (0.18) 0.27 (0.21) 0.62 (0.26) 0.67 (0.16) 0.69 (0.20) 0.59 (0.27) 0.31 (0.37) 430
3D U-Net- 0.60 (0.19) 0.13 (0.27) 0.64 (0.24) 0.69 (0.10) 0.69 (0.12) 0.71 (0.48) 0.27 (0.33) 20
F. La Rosa, et al. NeuroImage: Clinical 27 (2020) 102335
7
challenges (Carass et al., 2017). In particular, we focused our study on
the CLs and WMLs detection rate, as well as the absolute volume dif-
ference, because lesion count and volume are included in the MS di-
agnostic criteria (Thompson et al., 2018). Among the metrics reported,
the PPV is a pixel-wise metric that by definition ignores the false ne-
gatives, which in our case represent the missed lesions, and are there-
fore quite important. Moreover, it should be noted that the widely used
dice coefficient is not reflecting well the overall performance in the case
of very small structures as in our study. For how it is computed, the dice
is naturally biased towards the lesion, penalizing cases with only small
structures more severely.
Table 1 shows that 3D U-Net- outperformed the other methods in all
metrics except for the PPV. The high detection rate for both WMLs and
CLs proves the capability of our proposed method to detect both types
of MS lesions with similar accuracy, even if the latter have a low con-
trast in the FLAIR images (see Figs. 1 and 5). Performing Wilcoxon
signed rank test using a Bonferroni correction for multiple comparisons,
3D U-Net- is significantly better than the other approaches in CL and
WML detection rate and in false positive rate. Our claims are also
supported by an analysis of the correlation between the manual total
lesion volume and the one automatically segmented (see Fig. 7).
Moreover, we explored the lesion detection rate per lesion size (Fig. 8).
By increasing the minimum lesion size all methods perform better, and
their relative difference in detection rate decreases.
In the independent test scenario, we trained the two supervised
methods with the patients of Dataset I and tested the models with the
subjects of Dataset II. In this way, we evaluated the methods on cases
acquired in another site and with a different scanner. We acknowledge,
however, that the acquisition parameters of both scanners were very
similar, thus limiting the generalization to this particular setting. It can
be observed in Table 2 that also in this independent test setting, the
supervised deep learning approaches outperform LST-LGA in terms of
lesion detection, dice coefficient, and also volume difference. NicM-
Slesions significantly improves with respect to the previous scenario its
false positive rate (p-value < 0.01) and reaches the best WM LTPR
together with 3D U-Net- (69%). Thus, these results support previous
claims of generalizing very well in WML segmentation to cases from
different datasets (Valverde et al., 2019; Weeda et al., 2019). Moreover,
let us note that in this study we assessed nicMSlesions considering a
much smaller minimum lesion size than in any other previous study
where it was tested (Valverde et al., 2017, 2019; Weeda et al., 2019).
Compared to a 69% WML detection rate, nicMSlesions CL detection rate
was only 59%. We hypothesize this is due to the dependency of its
lesion candidate selection on the FLAIR intensity value. As the sensi-
bility of FLAIR to CLs is limited, several CLs might be discarded for this
reason. Interestingly, 3D U-Net- performs even better than in the first
scenario in terms of volume difference (p-value < 0.05), but under-
standably performs slightly worse in cortical and white matter LTPR (p-
value N.S.). In particular, it reaches the same result as nicMSlesions
(69%) in terms of WMLs, but it performs significantly better for the CLs
detection rate (71% vs 59%, p-value < 0.05, Wilcoxon signed rank
test). Furthermore, is worth noting that in this scenario the ground
truth of the training and testing datasets was delineated by different
experts. This might contribute to intrinsic differences in the labeled
masks, thus posing additional challenges to the automatic methods.
A major advantage of our CL and WML segmentation framework is
that it is based on two 3T MRI sequences only. As successfully done in
previous automatic segmentation studies (Fartaria et al., 2016, 2017; La
Rosa et al., 2019), we explore the use of the specialized MP2RAGE
sequence instead of the conventional MPRAGE. Nonetheless, we ac-
knowledge that this sequence is still not widely acquired in clinical
routine for MS. However, in order to visually detect CLs, specialized
sequences are needed (Calabrese et al., 2010; Filippi et al., 2019), and
the MP2RAGE is a promising substitute of the conventional MPRAGE.
MP2RAGE has increased lesion and tissue contrast compared to the
common MPRAGE (Kober et al., 2012). Moreover, while currently the
MP2RAGE sequence requires about 8 min of scanning time protocol,
recent developments have shown that its acquisition time can be re-
duced to less than 4 min without compromising the image quality
(Mussard et al., 2020). Thus, it could easily be included (additionally to
or instead of the MPRAGE) in a 3T MRI MS clinical protocol in order to
support the CLs analysis.
In contrast to other studies, we report the detection accuracy of very
small lesions that when evaluated using an overlap measure, such as
Dice coefficient, and in presence of large lesions would not contribute
strongly to the performance evaluation but may be clinically relevant.
However, our method detected very small lesions (between 3 and 10
voxels, 3–10 µL) poorly. We believe this is due to partial volume effect
and artefacts affecting them and could be improved if more small le-
sions would be included in the training dataset. In our study, experts
agreed by consensus on the lesion detection, but the ground truth masks
of each dataset were manually delineated only once and by different
experts. This limits our analysis, not allowing us to compare the auto-
matic methods' performance to the inter and intra rater reliability.
Moreover, given the 3T MRI settings of our work, the vast majority of
CLs detected by the experts (89%) are leukocortical/juxtacortical. Thus,
also the accurate CL detection of our proposed method is limited to this
particular CL type.
In conclusion, we achieve an accurate CLs and WMLs segmentation
with a simple 3D fully-convolutional CNN, which operates on data that
is not treated with advanced pre-processing, is fast to run at inference
time and generalizes well across two different scanners. The considered
MRI sequences are close to the ones of a clinical scenario, meaning that
the proposed approach could support experts in the lesion segmentation
process. Future work will aim at improving the lesion delineation. This
might include, for instance, exploring the T1 map acquired together
with the MP2RAGE sequence. Moreover, we will tackle the challenging
task of providing an output segmentation that classifies the lesions in
WMLs and CL types, as this could have an added clinical value.
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